Free

E-newsletter

Subscribe to Housecall

Our weekly general interest
e-newsletter keeps you up to date on a wide variety of health topics.

Sign up now

Definition

By Mayo Clinic staff

The quad screen — also known as the quadruple marker test or simply the quad test — is a prenatal test that measures levels of four substances in a pregnant woman's blood:

  • Alpha-fetoprotein (AFP), a protein made by the developing baby
  • Human chorionic gonadotropin (HCG), a hormone made by the placenta
  • Estriol, a hormone made by the placenta and the baby's liver
  • Inhibin A, another hormone made by the placenta

Typically, the quad screen is done between weeks 15 and 20 of pregnancy — the second trimester.

Results of the quad screen indicate your risk of carrying a baby who has certain chromosomal conditions, such as Down syndrome. The alpha-fetoprotein part of the test can help detect neural tube defects, such as spina bifida.

If your risk level is low, the quad screen can offer reassurance of a healthy pregnancy.

If your risk level is moderate or high, you might choose to follow the quad screen with another test that's more definitive.

References
  1. Canick JA, et al. Second trimester maternal serum screening for Down syndrome. http://www.uptodate.com/index. Accessed Aug. 27, 2012.
  2. Canick JA, et al. Laboratory issues related to maternal serum screening for Down syndrome. http://www.uptodate.com/index. Accessed Aug. 27, 2012.
  3. Canick JA, et al. First trimester and integrated screening for Down syndrome and trisomy 18. http://www.uptodate.com/index. Accessed Aug. 27, 2012.
  4. NINDS anencephaly information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/anencephaly/anencephaly.htm. Accessed Aug. 27, 2012.
  5. NINDS spina bifida information page. National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/spina_bifida/spina_bifida.htm. Accessed Aug. 27, 2012.
  6. Ostermaier KK. Management of Down syndrome. http://www.uptodate.com/index. Accessed Aug. 27, 2012.
  7. Routine tests in pregnancy. American College of Obstetricians and Gynecologists. http://www.acog.org/~/media/For%20Patients/faq133.pdf?dmc=1&ts=20120827T1517335564. Accessed Aug. 27, 2012.
  8. Bianchi DW, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstetrics & Gynecology. 2012;119:890.
  9. Harms RW (expert opinion). Mayo Clinic, Rochester, Minn. Aug. 28, 2012.
MY00127 Oct. 13, 2012

© 1998-2013 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

  • Reprints
  • Print
  • Share on:

  • Email

Advertisement


Text Size: smaller largerlarger